These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 4600624

  • 21. The bacteriology of Mycobacterium leprae.
    Draper P.
    Tubercle; 1983 Mar; 64(1):43-56. PubMed ID: 6405519
    [No Abstract] [Full Text] [Related]

  • 22. The uptake of 3H-thymidine in Mycobacterium leprae inoculated mouse macrophage cultures as a rapid indicator of bacillary viability. Factors influencing the specificity of the in vitro assay.
    Sathish M, Nath I.
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):187-93. PubMed ID: 7024148
    [Abstract] [Full Text] [Related]

  • 23. Alternate radiolabeled markers for detecting metabolic activity of Mycobacterium leprae residing in murine macrophages.
    Prasad HK, Hastings RC.
    J Clin Microbiol; 1985 May; 21(5):861-4. PubMed ID: 3889052
    [Abstract] [Full Text] [Related]

  • 24. Mycobacterium leprae and phenoloxidase activity.
    Kim SJ, Ishaque M, Kato L.
    Microbios; 1978 May; 22(89-90):143-53. PubMed ID: 113650
    [Abstract] [Full Text] [Related]

  • 25. Metabolic inhibitors of host-tissue origin in Mycobacterium leprae.
    Prabhakaran K, Harris EB, Kirchheimer WF.
    Lepr India; 1979 Jul; 51(3):348-57. PubMed ID: 117257
    [Abstract] [Full Text] [Related]

  • 26. [Characteristics of distribution and elimination of DOPA-H3 and naphthidone-H3 in various forms of tumors].
    Shishkina VV, Chebotareva ED, Bobrova VN, Korolev VI, Idlis SM.
    Vrach Delo; 1978 Jun; (6):96-100. PubMed ID: 695486
    [No Abstract] [Full Text] [Related]

  • 27. Failure of Mycobacterium leprae to incorporate tritiated thymidine administered in vivo.
    Evans MJ, Levy L.
    Lepr Rev; 1977 Mar; 48(1):27-34. PubMed ID: 323610
    [No Abstract] [Full Text] [Related]

  • 28. The uptake and localization of radioactive DOPA by amphibian melanoblasts in vitro.
    Model PG, Dalton HC.
    Dev Biol; 1968 Mar; 17(3):245-71. PubMed ID: 5642023
    [No Abstract] [Full Text] [Related]

  • 29. Pyrimidine scavenging by Mycobacterium leprae.
    Wheeler PR.
    FEMS Microbiol Lett; 1989 Jan 15; 48(2):179-84. PubMed ID: 2656380
    [Abstract] [Full Text] [Related]

  • 30. Distribution of DOPA-2- 14 C in relation to DOPA-1- 14 C (carboxyl- 14 C-labelled DOPA) in mice before and after inhibition of DOPA-decarboxylase, studied by whole-body autoradiography.
    Tjälve H, Ullberg S.
    Arch Int Pharmacodyn Ther; 1972 Oct 15; 199(2):376-88. PubMed ID: 4627124
    [No Abstract] [Full Text] [Related]

  • 31. Inhibitory activity and mode of action of diaminodiphenylsulfone in cell-free folate-synthesizing systems prepared from Mycobacterium lufu and Mycobacterium leprae. A comparison.
    Kulkarni VM, Seydel JK.
    Chemotherapy; 1983 Oct 15; 29(1):58-67. PubMed ID: 6339181
    [Abstract] [Full Text] [Related]

  • 32. Rapid test for drug resistance in leprosy.
    Ambrose EJ, Khanolkar SR, Antia NH, Chulawalla RG, Koticha KK.
    Lancet; 1977 Nov 12; 2(8046):1036. PubMed ID: 72940
    [No Abstract] [Full Text] [Related]

  • 33. In vitro activities of phenothiazine-type calmodulin antagonists against Mycobacterium leprae.
    Dhople AM.
    Microbios; 1999 Nov 12; 98(390):113-21. PubMed ID: 10624009
    [Abstract] [Full Text] [Related]

  • 34. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). II. Autoradiographic study on the distribution of 14 C-labeled D- and L-DOPA after oral administration in rats.
    Shindo H, Miyakoshi N, Nakajima E.
    Chem Pharm Bull (Tokyo); 1972 May 12; 20(5):966-73. PubMed ID: 5055126
    [No Abstract] [Full Text] [Related]

  • 35. Editorial: Leprous leukoderma.
    Trans St Johns Hosp Dermatol Soc; 1973 May 12; 59(1):129-30. PubMed ID: 4585247
    [No Abstract] [Full Text] [Related]

  • 36. Hypopigmentation of skin lesions in leprosy--a hypothesis.
    Prabhakaran K.
    Lepr India; 1977 Jul 12; 49(3):462-3. PubMed ID: 338986
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Selective 2-[18F]fluorodopa uptake for melanogenesis in murine metastatic melanomas.
    Ishiwata K, Kubota K, Kubota R, Iwata R, Takahashi T, Ido T.
    J Nucl Med; 1991 Jan 12; 32(1):95-101. PubMed ID: 1899113
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.